Search Result "tremelimumab"
Immune Checkpoints Aberrations and Malignant Mesothelioma: Assessment of Prognostic Value and Evaluation of Therapeutic Potentials
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 9 Year: 2017 Page: 1228-1233
Author(s): Hadeer Mohamed,Mostafa Eltobgy,Omar Abdel-Rahman
CTLA-4: As an Immunosuppressive Immune Checkpoint in BreastCancer
Journal: Current Molecular Medicine
Volume: 23 Issue: 6 Year: 2023 Page: 521-526
Author(s):
Progress in the Understanding of the Immune Microenvironment and Immunotherapy in Malignant Pleural Mesothelioma
Journal: Current Drug Targets
Volume: 21 Issue: 15 Year: 2020 Page: 1606-1612
Author(s): Lei Cheng,Na Li,Xiao-ling Xu,Wei-Min Mao
Pharmacological Profile of Novel Anti-cancer Drugs Approved byUSFDA in 2022: A Review
Journal: Current Molecular Medicine
Volume: 24 Issue: 6 Year: 2024 Page: 734-750
Author(s): Parveen Kumar Goyal
The Therapeutic Potential of Targeting the Toll-like Receptor Pathway in BreastCancer
Journal: Current Pharmaceutical Design
Volume: 28 Issue: 27 Year: 2022 Page: 2203-2210
Author(s): Seyed Mahdi Hassanian,Gordon A. Ferns
Therapeutic Potential of Targeting Transforming Growth Factor-beta(TGF-β) and Programmed Death-ligand 1 (PD-L1) in Pancreatic Cancer
Journal: Current Drug Targets
Volume: 24 Issue: 17 Year: 2023 Page: 1335-1345
Author(s):
Immune Checkpoint Inhibitors for Non-small-cell Lung Cancer: Does that Represent a ‘New Frontier’?
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15 Issue: 3 Year: 2015 Page: 307-313
Author(s): Sara Pilotto,Stefania Kinspergher,Umberto Peretti,Anna Calio,Luisa Carbognin,Roberto Ferrara,Matteo Brunelli,Marco Chilosi,Giampaolo Tortora,Emilio Bria
Immune Checkpoint Inhibitors for Advanced Biliary Tract Cancer
Journal: Current Cancer Drug Targets
Volume: 22 Issue: 8 Year: 2022 Page: 639-650
Author(s): Gerald W. Prager
Immunotherapy for the Treatment of Hepatocellular Carcinoma
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 12 Year: 2021
Author(s): Georgios Tsoulfas,Ioannis A. Ziogas,Stepan M. Esagian
Doi: 10.2174/9789811487385121120006
Targeted Therapies in Metastatic Melanoma: Toward a Clinical Breakthrough?
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10 Issue: 9 Year: 2010 Page: 661-665
Author(s): Fanny Julia, Luc Thomas, Charles Dumontet, Stephane Dalle